![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, January 14, 2018 11:43:52 AM
Sure would be interesting to know what is the focus of Dr M at the current time. Just thinking about B, do they go after the IBD side or the dermatology side? Hope we get a large, top line partner to be able to address concurrently. For K, I hope the line is already forming by current top line treatments to conduct combo research with their products. If that is the case, does IPIX need a K partner at the current time or would we be able to ride the combo trials and partner with each successful indication for that particular treatment? Don't know if I am making myself clear, but IPIX provides the K and researcher provides the funding for the combo trial with their product. Like the U of Bologna trial from years past.
Obvious from the above musings that I consider chances very high that all three drugs will receive very positive P2 results and that all will be examined for further indications.
Quick query - K has advanced steadily in the area of greatest activity by cancer research -- p53. How come we have seen nothing in the way of funding by the Cancer Society when they bring in billions upon billions yearly? Hate to say it, but I am highly dubious of ALL charities, except for those like St. Judes, Shriners, etc where nearly 100% of acquired funds go to the hospital and patients themselves.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM